Methyl-prednisolone up-regulates monocyte interleukin-10 production in stimulated whole blood

Scandinavian Journal of Immunology

Volumn 49, Issue 5, 1999, Pages 548-553

  Hodge, S ^a,b   Hodge, G ^a,b   Flower, R ^a   Han, P ^b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; CALCIUM IONOPHORE; DEXAMETHASONE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GAMMA INTERFERON; GLUCOCORTICOID; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; PHORBOL ESTER; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC DISEASE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; BLOOD; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MONOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; ANTI-INFLAMMATORY AGENTS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-10; METHYLPREDNISOLONE; MONOCYTES; UP-REGULATION;

EID: 0033024536     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00538.x     Document Type: Article

References (32)

1. Dutoit JI, Salome CM, Woolcock AJ. Inhaled corticosteroids reduce the severity of bronchial hyperresponsiveness in asthma but oral theophyline does not. Am Rev Respir Dis 1987;136:1174-8.
2. Kraan J, Koeter GH, Mark TW, Sluiter HJ, de Vries K. Changes in bronchial hyperreactivity by four weeks treatment with anti-asthmatic drugs in patients with allergic asthma. A comparison between budesonide and terbutaline. J Allergy Clin Immunol 1985;76:628-36.
3. Krouwels F, van der Heijden J, Lutter R, van Neerven J, Jansen H, Out T. Glucocorticosteroids affect functions of airway- and blood-derived human T-cell clones, favouring the Th1 profile through two mechanisms. Am J Resp Cell Mol Biol 1996;14:388-97.
4. Brattsand R, Linden M. Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment-Pharmacol-Ther 1996;10:81-90.
5. Fushimi T, Okayama H, Seki T, Shimura S, Shirato K. Dexamethasone suppressed gene expression and production of interleukin-10 by human peripheral blood mononuclear cells and monocytes. Int Arch Allergy Immunol 1997;112:13-8.
6. van Furth A, Seijmonsbergen E, Langermans J, van der Meide P, van Furth R. Effect of xanthine derivates and dexamethasone on Streptococcus pneumoniae-stimulated production of tumour necrosis factor alpha, interleukin 1β (IL-1β), and IL-10 by human leukocytes. Clin and Diag Lab Immunol 1995;2:689-92.
7. Kraan J, Koeter GH, van der Mark TW et al. Dosage and time effects of inhaled budesonide on bronchial hyperreactivity. Am Rev Respir Dis 1988;137:44-8.
8. Matthias J, Lim S, Seybold J et al. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1α, granulocyte-macrophage colony-stimulating factor, and interferon-γ release from alveolar macrophages in asthma. Am J Respir Crit Care Med 1998;157:256-62.
9. van der Prouw Kraan TC, Boeije LC, Smeenk RJ et al. Prostaglandin-E2 is a potent inhibitor of interleukin 12 production. J Exp Med 1995;181:775-9.
10. 2-Agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest 1997;100:1513-9.
11. 3. J Clin Invest 1998;101:252-62.
12. Pretolani M, Goldman M. IL-10: a potential therapy for allergic inflammation. Immunol Today 1997;18:277-80.
13. Quayle AJ, Chomarat P, Miossec P, Kjeldsen-Kragh J, Forie O, Natuig JB. Rheumatoid inflammatory T-cells express mostly ThI but also Th2 and mixed (Th0-like) cytokine patterns. Scand J Immunol 1993;38:75-82.
14. + T-cell clones and peripheral blood T-cells. J Immunol 1992;149:2378-84.
15. deWaal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes. An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
16. Schandene L, Alonso-Vega C, Willems F. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J Immunol 1994;152:4368-74.
17. del Prete G, de Cadi M, Almerigogna F, Giudizi G, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150:353-60.
18. Fiorentino DF, Bond MW, Mosmann TR. IL-10 and viral IL-10 strongly reduce antigen-specific human T-cell proliferation by diminishing the antigen presenting capacity of monocytes via down-regulation of class II major histocompatability complex expression. J Exp Med 1991;174:915.
19. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993;11:165-90.
20. Wilckens T, de Rijk R. Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol Today 1997; 18:418-23.
21. DeGroot D, Zangerle PF, Gevaert Y et al. Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992;4:239-48.
22. Wadhwa M, Seghatchian MJ, Lubenko A et al. Cytokine levels in platelet concentrates: quantitation by bioassays and immunoassays. Br J Haematol 1996;93:225-34.
23. Bordin JO, Heddel NM, Blajchman MA. Biological effects of leucocytes present in transfused cellular blood products. Blood 1994;84:1703-21.
24. Picker LJ, Singh MK, Zdraveski z Treer JR, Waldrop SL, Bergstresser PR, Maino VC. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 1995;86:1408-19.
25. Assenmacher M, Schmitz J, Radbruch A. Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of IL-10 in interferon-gamma and in interleukin-4 expressing cells. Eur J Immunol 1994;24:1097-101.
26. Maino VC, Ruitenberg JJ, Suni MA. Flow cytometric method for analysis of cytokine expression in clinical samples. Clin Immunol Newsletter 1996;16:95-8.
27. Ferry B, Antrobus P, Huzicka I, Farrell A, Lane A, Chapel H. Intracellular cytokine expression in whole blood preparations from normals and patients with atopic dermatitis. Clin Exp Immunol 1997;110:410-7.
28. Hodge SJ, Hodge GL, Flower R, Han P. Surface activation markers of T lymphocytes: role in the detection of infection. Clin Exp Immunol 1998;113:33-8.
29. Thorpe R, Wadhwa M, Bird C, Mire-Sluis A. Detection and measurement of cytokines. Blood Rev 1992;6:133-48.
30. Visser J, Vries P. Identification and purification of murine haemopoietic stem cells by flow cytometry. In: Darzynkiewicz Z, Crissman H eds. Methods in Cell Biology. San Diego: Academic Press, 1990:451-68.
31. Dive C, Gregory C, Phipps D, Evans D, Milner A, Wylie A. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparametric flow cytometry. Biochim Biophys Acta 1992;1133:275-85.
32. D'Andrea A, Miguel AA, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-2 synthesis in accessory cells. J Exp Med 1993;178:1041-8.